In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
InspireMD Inc (NASDAQ: NSPR) closed the day trading at $1.78 down -5.82% from the previous closing price of $1.89. In other words, the price has decreased by -$5.82 from its previous closing price. On the day, 0.13 million shares were traded. NSPR stock price reached its highest trading level at $1.91 during the session, while it also had its lowest trading level at $1.66.
Ratios:
For a better understanding of NSPR, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.17 and its Current Ratio is at 6.51. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.04.
Upgrades & Downgrades
. In the most recent recommendation for this company, Rodman & Renshaw on January 07, 2016, initiated with a Buy rating and assigned the stock a target price of $4.
On November 26, 2013, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $6.Oppenheimer initiated its Outperform rating on November 26, 2013, with a $6 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 09 ’25 when Stuka Paul bought 5,073 shares for $1.81 per share. The transaction valued at 9,182 led to the insider holds 391,628 shares of the business.
Stuka Paul bought 5,073 shares of NSPR for $9,436 on Dec 05 ’25. The Director now owns 388,918 shares after completing the transaction at $1.86 per share. On Dec 04 ’25, another insider, Stuka Paul, who serves as the Director of the company, bought 10,130 shares for $1.85 each. As a result, the insider paid 18,740 and bolstered with 383,845 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NSPR now has a Market Capitalization of 75420368 and an Enterprise Value of 15390371. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.69 while its Price-to-Book (P/B) ratio in mrq is 1.16. Its current Enterprise Value per Revenue stands at 1.978 whereas that against EBITDA is -0.331.
Stock Price History:
The Beta on a monthly basis for NSPR is 0.71, which has changed by -0.2894737 over the last 52 weeks, in comparison to a change of 0.17511821 over the same period for the S&P500. Over the past 52 weeks, NSPR has reached a high of $3.80, while it has fallen to a 52-week low of $1.59. The 50-Day Moving Average of the stock is -10.89%, while the 200-Day Moving Average is calculated to be -24.33%.
Shares Statistics:
Over the past 3-months, NSPR traded about 106.47K shares per day on average, while over the past 10 days, NSPR traded about 48230 shares per day. A total of 41.92M shares are outstanding, with a floating share count of 28.66M. Insiders hold about 32.35% of the company’s shares, while institutions hold 49.66% stake in the company. Shares short for NSPR as of 1765756800 were 66231 with a Short Ratio of 0.62, compared to 1763078400 on 43116. Therefore, it implies a Short% of Shares Outstanding of 66231 and a Short% of Float of 0.19.
Earnings Estimates
The dynamic stock of InspireMD Inc (NSPR) is currently attracting attention from 2.0 analysts actively involved in rating its market status.The consensus estimate for the next quarter is -$0.2, with high estimates of -$0.19 and low estimates of -$0.22. Analysts are recommending an EPS of between -$0.81 and -$0.88 for the fiscal current year, implying an average EPS of -$0.85. EPS for the following year is -$0.81, with 2.0 analysts recommending between -$0.79 and -$0.82.
Revenue Estimates
2 analysts predict $2.62M in revenue for . The current quarter. It ranges from a high estimate of $2.74M to a low estimate of $2.5M. As of . The current estimate, InspireMD Inc’s year-ago sales were $1.95MFor the next quarter, 2 analysts are estimating revenue of $2.36M. There is a high estimate of $2.42M for the next quarter, whereas the lowest estimate is $2.3M.
A total of 2 analysts have provided revenue estimates for NSPR’s current fiscal year. The highest revenue estimate was $8.57M, while the lowest revenue estimate was $8.3M, resulting in an average revenue estimate of $8.44M. In the same quarter a year ago, actual revenue was $7.01MBased on 2 analysts’ estimates, the company’s revenue will be $14.79M in the next fiscal year. The high estimate is $15.19M and the low estimate is $14.4M.
